Figure 1
Figure 1. Impact of number of nonpermissive mismatches on severe aGVHD and overall survival. (A) Cumulative incidence of severe aGVHD according to number of nonpermissive mismatches. –– indicates full match (in HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1) group; ----, zero nonpermissive mismatch (with mismatches other than nonpermissive mismatches) group; · · · ·, one nonpermissive mismatch (with or without mismatches other than nonpermissive mismatches) group; and – – –, 2 or more nonpermissive mismatches (with or without mismatches other than nonpermissive mismatches) group. (B) Kaplan-Meier estimates of survival according to number of nonpermissive mismatches. Each group was divided as described for panel A.

Impact of number of nonpermissive mismatches on severe aGVHD and overall survival. (A) Cumulative incidence of severe aGVHD according to number of nonpermissive mismatches. –– indicates full match (in HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1) group; ----, zero nonpermissive mismatch (with mismatches other than nonpermissive mismatches) group; · · · ·, one nonpermissive mismatch (with or without mismatches other than nonpermissive mismatches) group; and – – –, 2 or more nonpermissive mismatches (with or without mismatches other than nonpermissive mismatches) group. (B) Kaplan-Meier estimates of survival according to number of nonpermissive mismatches. Each group was divided as described for panel A.

Close Modal

or Create an Account

Close Modal
Close Modal